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Thymus-derived  lymphocytes exert  a  number of regulatory and effector activities 
in the immune system. Evidence has accumulated in recent years that these activities 
are  largely  executed  by  distinct  subsets  of T  cells  that  can  be  distinguished  by 
particular  cell  surface  antigens  (1,  2).  This  has  led  to  the  concept  of a  complex 
network of T  cell types, each endowed with its own specific function. Rigorous proof 
of this  concept  has  been  difficult  to  achieve  with  heterogeneous  cell  populations. 
Recently,  it  has  been  possible  to  establish  and  maintain  for  prolonged  periods  in 
culture  antigen-specific  T  cell  lines  (3,  4),  paving  the  way  to  a  more  definitive 
approach to this question. Homogeneous populations of antigen-specific T  cells should 
also  prove extremely  useful  for studies  of the  chemical  nature  of the  antigen  in  its 
activating form, as well as the nature of the T  cell antigen receptor itself. In addition, 
comparison of these parameters between different functional subsets of T  cells specific 
for the same antigenic determinant  should be possible. 
We report here the establishment, genetic control, and preliminary characterization 
of the antigen specificity of normal T  cell lines specifically responsive to a structurally 
defined epitope, L-tyrosine-p-azobenzenearsonate (ABA-Tyr)) It had been established 
previously (5,  6)  that this simple synthetic compound is immunogenic in guinea pigs 
and  mice. Accordingly, A/J  mice were immunized with ABA-Tyr, and  lymph node 
cells  from the  immune  animals  were used  to establish  antigen-reactive  T  cell  lines. 
Strain  A/J  mice  were  chosen  for  this  purpose  because  their  anti-ABA  antibody 
response is dominated by a major cross-reactive idiotype (7), providing the possibility 
of useful  markers  for the purification  and characterization  of T  cell antigen-specific 
molecules  as  well  as  studies  of the  regulation  of idiotype  expression  in  antibody 
responses.  The functional  activity of these ABA-Tyr-specific T  cell  lines will  be the 
subject of another communication. 
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Materials  and  Methods 
Mice.  A/J,  A.BY/Sn,  C3H.SW/Sn,  C57BL/6  (B6),  C57BL/10  (BI0),  B10.A,  B10.BR, 
B 10.D2/Sn, and B 10.A(5R) strains of mice were purchased from The Jackson Laboratory, Bar 
Harbor,  ME. B 10.M,  B 10.S,  B 10.G, and  B 10.A(18R)  strains of mice were kindly provided by 
Dr. J. Stimpfling (McLaughlin Institute, Great Falls, MT). B 10.A(2R), B 10.A(3R), B 10.A(4R), 
and B 10.MBR strains of mice were provided by Dr. Chella David (The Mayo Clinic, Rochester, 
MN). DBA/2 and  (C57BL/6  X DBA/2)F1 (BDF1) mice were purchased  from Diablo Labora- 
tories, Berkeley, CA. C57BL/Ka mice were provided by Dr. Henry Kaplan (Dept. of Radiology, 
Stanford University, Palo Alto, CA), and  (CBA/N X CAL.20)FI mice were either bred  in our 
colony or were provided by Dr. R. T. Woodland.  Female mice 6-10 wk of age were used in all 
experiments. 
Antigens  and  Immunizations.  The  azobenzenearsonate  derivatives  of tyrosine  and  histidine 
were  prepared  as  previously  described  (5,  6).  Tuberculin  purified  protein  derivative  (PPD- 
CT68)  from Mycobacterium  tuberculosis" was  purchased  from  Connaught  Laboratories,  Ontario, 
Canada. Mice were primed with a total of 0.15 mg of ABA-Tyr emulsified in complete Freund's 
adjuvant  (CFA)  (H37Ra;  Difco Laboratories,  Detroit, MI)  in the hind  footpads and  the base 
of the tail (8). 
Antigen-specif&  T  Celt Proliferative  Assay.  Lymph  node cell suspensions  were prepared  from 
draining lymph nodes  (inguinal,  popliteal, and para-aortic)  7 d  after immunization, and  5  X 
105 viable cells were cultured  in 0.2  ml of Click's medium containing 0.5% normal  syngeneic 
mouse  serum  and  supplemented  with  5  ×  10  5 M  2-mercaptoethanol  (2-ME),  50  ~tg  m1-1 
gentamycin,  and  2 mM  L-glutamine  in  flat-bottomed  microtiter plates  (Microtest  II; Falcon 
Labware, Becton, Dickinson & Co., Oxnard, CA). PPD  (10/~g ml  i) and concanavalin A  (Con 
A)  (1 /~g m1-1)  were used in some cultures in all experiments as positive controls. The cultures 
were kept at 37°C/5% COz for 3  4 d. 4 h before harvest,  1/tCi of [aH]thymidine (New England 
Nuclear,  Boston,  MA)  (20 Ci/mM)  was added  to each culture.  Cells were harvested using a 
semiautomatic cell-harvester and counted in a  Packard  Liquid Scintillation Counter (Packard 
Instrument  Co.,  Downers  Grove,  IL).  The  data  were  expressed  as  the  arithmetic  mean  of 
triplicate  cultures.  In  inhibition  experiments  using  monoclonal  antibodies,  1 /tg of purified 
protein was added to each well upon  initiation of culture. 
Monoclonal Antibodies.  The hybridoma cell lines used in this investigation are listed in Table 
I. The cell lines were either obtained  from the originators or from the American Type Culture 
Collection, Bethesda, MD. 
To obtain  culture  supernatants,  cells were overgrown in an  equal  mixture  of RPMI  1640 
and Ham's F12 containing  10/,tg/m1-1  each of insulin and  transferrin,  2 mM L-glutamine,  10 
mM Hepes, 50/~g/ml gentamycin, 5 ×  10 -s M 2-ME, and in some instances 1% heat-inactivated 
TABLE  i 
Monoclonal Antibo&'es 
Subclass mouse 
Clone  hybridomas  Specificity  Reference 
10-2.16  y2a, x  I-A  k'f'r'~  10 
10-3.6  y2a, x  I-A  k'f;r'~  10 
17-3-3  y2a, ~  I-E  k  11 
14-4-4S  y2a, x  I-E  k*  11 
Y- 17  y2a, ~  I-E  k*  12 
[fO-13  ¢t, x  Thy-l.2  13 
Rat 
hybridomas 
53.7.3  y2a  Lyt- 1  14 
53.6.7  y2a  Lyt-2  14 
* Combinatorial determinam. HERTEL-WULFF ET  AL.  989 
fetal calf serum.  Hybridoma antibodies were purified from the supernatants by fractionation 
on protein-A Sepharose as described by Oi (15). 
ABA- Tyr Reactive T Cell Lines.  ABA-Tyr reactive T cell lines from A/J mice were established 
as described by Kimoto and  Fathman  (16).  Briefly, the technique was modified as follows: 
Lymph node cells from ABA-Tyr primed mice were cultured with 100/~g/m1-1  ABA-Tyr. 2 wk 
later cells were harvested and serially restimulated every 10-14 d with ABA-Tyr in the presence 
of irradiated (3,000  rad) A/J spleen cells. The bulk cultures were cloned by limiting dilution or 
by the fluorescence-activated cell sorter (FACS) after the sixth to ninth  restimulation. Cells 
were cloned at limiting dilution by culturing 0.5-10 T cells per 0.2 ml well of a Falcon Microtest 
II plate. Each culture contained 2.5  ×  105 irradiated A/J spleen cells and  25-250 p.g/ml of 
antigen in complete medium supplemented to 20% (vol/vol) with a supernatant from Lewis rat 
spleen cells stimulated for 24 h with Con A. Alpha methyl mannoside was added at 20 mg/ml 
to the Con A  supernatant  to prevent stimulation by Con A. FACIS cloning was carried out 
under identical culture conditions. In this procedure, a  single viable cell was deposited into 
each well of a 96-well Microtest II plate using a Becton Dickinson sorter cloning attachment for 
the FACS-IV (B-D FACS Systems, Sunnyvale, CA). Wells were positive for growth after 2-4 
wk of culture. The cloned cell lines were raised and kept in  10% fetal calf serum/RPMI  1640 
supplemented with 5 X 10  -5 M 2-ME, 2 mM L-glutamine, penicillin (100 U ml-1), streptomycin 
(100 ~g ml-I), 10 mM Hepes (16), plus 0.1%-0.25% supernatant from rat spleen cells stimulated 
with Con A. The cloning efficiency was -50% for the limiting dilution technique and 0.8% for 
the FACS. The reasons for this disparity are unknown, but two possibilities  must be entertained. 
One is that FACS sorting impairs cell viability, and the other is that wells receiving more than 
one cell, which will occur at higher frequency with limiting dilution, have a higher probability 
of growth. 
Results 
Lymph node cells (LNC)  from  various strains of mice immunized  7  d  previously 
with 0.15 mg of ABA-Tyr were tested for in vitro proliferation to ABA-Tyr (Table II). 
All strains  responded  significantly above background,  but  those of H-2 b haplotype 
were  consistently  lower  than  other  H-2  haplotypes  tested.  The  non-H-2  genetic 
background of the cells had no apparent influence on the response. Thus,  C57BL/6, 
C57BL/10,  C57BL/Ka,  A.BY,  and  C3H.SW  cells  all  proliferated  only  3-8  times 
above background, compared with stimulation ratios of 10-42 by non-H-2 b haplotype 
cells. Dominance or recessiveness of the high responder trait was evaluated using F1 
hybrid offspring between low responder C57BL/6 and high responder DBA/2 parents. 
Responsiveness proved  to be  dominant  inasmuch  as LNC  from  primed F1  animals 
proliferated to the same degree as LNC from DBA/2 mice (Table III). 
The influence of the xid gene (17) on responsiveness to ABA-Tyr was studied using 
offspring of CBA/N  female by CAL.20 male matings.  Lymph node cells from  male 
and  female Fa hybrid animals did not exhibit significant differences in their in vitro 
proliferative responses to ABA-Tyr (data not shown). 
The possible role of suppressor T  cells in the relatively poor response of cells from 
H-2  b mice was addressed in two ways. First, LNC from immune C57BL/6 mice were 
treated  with  anti-Lyt-2.2  antibody  and  complement  just  before  in  vitro  culture. 
Depletion of Lyt-2°positive cells from  the LNC  failed to alter the magnitude of the 
subsequent proliferative response (data not shown), suggesting that the low responder 
state  was  not  due  to  efferent  suppression.  Second,  to  explore  the  possibility that 
priming with  ABA-Tyr induces afferent  suppression, C57BL/6  mice were  given  20 
mg/kg -1  body weight  of cyclophosphamide  2  d  before antigen.  Primed  LNC  from 
treated and control animals gave proliferative responses to ABA-Tyr that  were  2.3- 
and  2.0-fold  above  background,  respectively (data  not  shown).  Thus,  the  findings 990  ARSONATE-SPECIFIC  MURINE  T  CELl,  CI,ONES 
TABLE  II 
Prohferative Response to ABA-Tyr by LNC Jkom Various Inbred Strains of 
Mzce 
Ue-  Experi-  tt-2 
ment  Strain  hapIo-  A cpm*  SR~c  sponder 
designa- 
number  type  tion{} 
Bl0  b  4,714  6.3  I, 
B 10.A  a  28,897  42.3  It 
B6/Ka  b  6,646  8.5  L 
A.BY  b  l 1,198  3.5  L 
C3It.SW  b  l 1,155  2.8  I, 
B10.A  a  14,618  26.0  tt 
B 10.A(18R)  i 18  3,774  3.9  L 
BI0.A  a  19,774  21.5  tt 
B10.S  s  22,182  17.4  1t 
B6  b  4,604  3.4  I, 
B 10.A  a  16,483  17.9  tt 
B10.BR  k  15,038  10.5  ti 
B10.D2  d  12,437  9.2  tt 
B l0  b  5,699  4.4  I, 
BI0.M  f  51,309  38.0  tt 
B10.S  s  38,828  22.5  tt 
B10.G  q  7,92l  7.0  ? 
* Proliferation expressed as  cpm obtained in the  presence of 400 #g/ml  of 
ABA-Tyr minus cpm obtained from cultures with the responder cells alone. 
$ Stimulation ratio: cpm in the presence of 40(1/Lg/ml of ABA-Tyr divided by 
cpm in the absence of antigen. 
{} L, low responder, H, high responder to ABA-Tyr. 
TABLE  III 
Responsiveness to ABA-Tyr Is Dominant in Ft Progeny of Low and High 
Responder Parental Strains 
Responder 
Strain  cpm*  SR~:  designation{} 
B6  2,379  3.0  I, 
DBA/2  22,675  13.8  H 
BDF 1  18,851  19.1  H 
*, :~, {} See Table II. 
indicate that T  suppressor cells were not solely responsible for the low responder status 
of H-2  b  mice  to  ABA-Tyr.  They  do  not  exclude,  however,  the  possible  existence  of 
ABA-Tyr-specific suppressor T  cells in primed  animals. 
The  genetic  control  of responsiveness  to  ABA-Tyr  was  investigated  further  using 
B10  congenic  recombinant  strains.  Low  responder  status  was  manifested  only  by 
strains which were of b  haplotype  across the entire I region of the H-2 complex  (Table 
IV).  Thus,  of  the  strains  tested,  only  B10  and  B10.A(18R)  were  low  responders, 
whereas  strains that  were  I-A  b  [B10.A(3R)  and  B10.A(5R]  or  I-E  b  [B10.A(4R)],  but HERTEL-WULFF  ET  AL.  991 
TABLE  IV 
Genetic Restriction of T Cell Proliferation to ABA-Tyr 
Experi-  H-2 compo-  Re- 
sition  sponder  ment  Strain  cpm*  SR~: 
number  designa- 
K  A  E  D  tion§ 
B10  b  b  b  b  3,711  3.7  L 
B10.A(2R)  k  k  k  b  9,748  10.6  H 
BI0.A(3R)  b  b  k  d  23,673  15.6  H 
B 10.A(4R)  k  k  b  b  12,453  11.5  H 
B10.A(5R)  b  b  k  d  8,093  7.6  H 
BI0.A(3R)  b  b  k  d  23,224  13.7  H 
B10.A(4R)  k  k  b  b  10,485  6.2  H 
BI0.BR  k  k  k  k  14,503  7.9  H 
BI0  b  b  b  b  7,043  1.6  L 
BI0.MBR  b  k  k  k  30,850  4.7  H 
BI0.D2  d  d  d  d  46,329  5.9  H 
B10.A  k  k  k  d  14,618  26.0  H 
B10.A(18R)  b  b  b  d  1,111  2.4  L 
*, ~, § See Table If. 
TABLE  V 
Inhibition of T Cell Proliferation to ABA-Tyr by Monoclonal Anti-I-A  and 
Anti-I-E Antibo&es 
H-2 compo-  Aver-  Percent 
sition  Monoclonal  age  SR§  inhibi-  Strain  antibody*  cpm~:  tion 
K  A  E  D 
B10.A(4R)  k  k  b  b  None  4,549  7.2 
10-2.16  577  0.9  87_3 
17-3-3  3,986  6.3  12.4 
B10.A(5R)  b  b  k  d  None  4,740  5.5 
10-2.16  4,816  5.6  0 
17-3-3  1,356  1.2  71.4 
B10.A  k  k  k  d  None  5,970  10.4 
10-2.16  847  1.5  85.8 
17-3-3  2,016  3.5  66.2 
* 1 /~g of protein A purified protein per culture. 
:~ cpm in cultures of B10.A(4R), B10.A(5R), or B10.A LNC without ABA-Tyr 
were 642,855, or 572 cpm, respectively. 
§ See note to Table IL 
k  at the other respective locus, were of high responder phenotype.  The  indication that 
I-A and I-E loci were both implicated  in the response to ABA-Tyr  was further assessed 
by using monoclonal  anti-Ia antibodies  to  block proliferation  (Table V).  The  prolif- 
erative response of B 10.A cells was significantly inhibited  by both  10-2.16  (anti-I-A  k) 
and  17-3-3  (anti-I-Ek).  On  the  other  hand,  B10.A(4R)  cells  were  inhibited  only  by 
10-2.16  and  B10.A(5R)  cells  were  inhibited  only  by  17-3-3,  the  appropriate  mono- 
elonal  in  each  case.  The  combined  results  from  these  experiments  support  the 992  ARSONATE-SPECIFIC  MURINE T  CELL CLONES 
conclusion that  the responding T  cells in the proliferation  assay recognize ABA-Tyr 
in conjunction with I-A and/or I-E gene products. 
Cloned  T  cell  lines  were obtained  by limiting  dilution  of T  cells  from long-term 
culture of A/J LNC.  Using the proliferative assay, all clones responded  to ABA-Tyr 
and did not respond to PPD, to which the original LNC were highly responsive. The 
same  clones  in  different  experiments  gave  markedly  different  cpm  values,  so  cpm 
values themselves,  rather  than  ratios,  are given in the tables.  Although the basis  for 
the variation is unclear, it has been regularly observed in other laboratories working 
with cloned T  cells  (E.  Sercarz, personal communication). Treatment  of cloned cells 
with monoclonal anti-Thy-1 antibody and complement before the proliferative assay 
completely abrogated the response to ABA-Tyr, attesting to their Thy-1 positivity. 
The  proliferative  responses  to  ABA-Tyr  by  14  of  15  clones  were  inhibited  to 
background levels by the  10-2.16 and  10-3.6  monoclonal antibodies  (anti-I-A  k)  and 
not by Y-17,  14-4-4S, or  17-3-3  (anti-I-Ek). The data for a  representative  clone,  16-4, 
are shown in Table VI.  1 out of the  15 clones tested  (clone  16-5)  had its proliferation 
inhibited  to background levels by the anti-I-E  k, but not by the anti-I-A  k, monoclonal 
antibodies  (Table VI). This indicated that T  cells respons!ve to ABA-Tyr were either 
I-A or I-E region restricted.  The results  also established  the validity of the blocking 
protocol,  inasmuch  as  the  antibodies  were  selective  in  their  activity  and  were  not 
cytotoxic.  It  was  further  shown  that  clone  16-4  recognized ABA-Tyr presented  by 
B10.A(4R)  but  not  by  B10.A(3R)  feeder  cells,  the  response  to  which  was  totally 
inhibited  by anti-I-A  u but not at all by anti-I-E  k, monoclonal antibody (Table VI1). 
The  I-E  k restricted  clone  (16-5)  only  responded  to  ABA-Tyr  in  the  presence  of 
syngeneic  feeder  cells  (Table  VII).  Neither  B10.A(3R)  nor  B10.A(4R)  feeders  pre- 
sented  antigen  to this  clone.  The  inability  of B10.A(3R)  cells  to present  antigen  to 
clone  16-5  is  likely  due  to  the A be,  E~  phenotype  of this  strain,  inasmuch  as  the 
homologous A/J strain,  from which  the  clone was  derived,  is A~,  E~.  The  blocking 
TABLE VI 
Monoclonal Anti-Ia Antibodies Block Prohferation of Cloned 7' Cells 
to ABA-Tyr 
Monoclonal 
Clone*  ABA-Tyr  antibody{  cpm 
16-4 
16-5 
#g/ml 
None  None  77 
25  None  1  (/,899 
25  10-2.16  212 
25  10-3.6  316 
25  14-4-4S  15,958 
25  l 7-3-3  13,440 
None  None  320 
25  None  5,475 
25  10-2.16  5,295 
25  10-3.6  5,736 
25  14-4-4S  92 
25  17-3-3  271 
* 2 ×  104 cloned T cells plus 1 ×  106 irradiated A/J spleen cells per culture. 
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TABLE VII 
Response of T Cell Clones to ABA-Tyr in the Presence  of Feeder Cells with Different 
H-2 Haplotypes 
T cell  Antigen I.tg/ml  Feeder cetls~  MonoclonaI  Average 
clone*  antibody§  cpm 
16-4  None  A/J  None  434 
ABA-Tyr, 50  None  115,917 
ABA-Tyr, 50  10-2.16  410 
ABA-Tyr, 50  Y- 17  156,364 
None  B  10.A(4R)  None  68,966 
ABA-Tyr, 50  None  253,375 
ABA-Tyr, 50  10-2.16  1,421 
ABA-Tyr, 50  Y-17  252,767 
None  B 10.A  (3R)  None  170 
ABA-Tyr, 50  None  478 
ABA-Tyr, 50  10-2.16  179 
ABA-Tyr, 50  Y- 17  906 
16-5  None  A/J  None  1,643 
ABA-Tyr, 50  None  47,507 
ABA-Tyr, 50  10-2.16  26,203 
ABA-Tyr, 50  Y- 17  5,218 
None  B  10.A  (4R)  None  677 
ABA-Tyr, 50  None  1,248 
ABA-Tyr, 50  10-2.16  198 
ABA-Tyr, 50  Y- 17  846 
None  B  10.A(3R)  None  517 
ABA-Tyr, 50  None  1,180 
ABA-Tyr, 50  10-2.16  435 
ABA-Tyr, 50  Y-17  1,380 
* 2 ×  10  4 cells per culture. 
~: l ×  10  n irradiated spleen 
§ See *, Table IV. 
cells per culture. 
studies with monoclonal antibody Y-17 suggest that clone 16-5 recognizes ABA-Tyr 
in the presence of a combinatorial determinant between Ae and EI~. 
The fine antigen specificity of the clones was studied using structural analogs of the 
homologous antigen, ABA-Tyr, to  induce proliferation. The  most  interesting data 
were obtained with histidine derivatives of azobenzenearsonate. The clones could be 
divided into three types with respect  to responsiveness to ABA-histidine (ABA-His). 
One type  responded about  equally well  to  ABA-Tyr and 4-ABA-His (Table VIII, 
clones 16-4 and 16-F1). A second group responded less strongly to 4-ABA-His than to 
ABA-Tyr (Table VIII, clones  16-2  and  16-F2), whereas a  third set gave no response 
above background to 4-ABA-His (data not shown). In all instances, the 4-ABA-His 
responsive clones  discriminated exquisitely between  the  2-azo  and  4-azo  histidine 
isomers, responding only to  the 4-azo compound (2-azo responses not shown). The 
responses to 4-ABA-His were blocked by  10-2.16 monoclonal anti-I-A  k antibody, as 
were responses to ABA-Tyr (Table VIII). Thus, these T  cell clones manifest distinctly 994  ARSONATE-SPECIFIC  MURINE  T  CELL CLONES 
TABLE  VIII 
Fine SpecS'city of ABA-Tyr Responsive T Cell Clones 
Clone*  Antigen 25/~g/ml  Antibody  10-2.16  cpm 
16-2  None  None  1,620 
ABA-Tyr  None  l 17,043 
ABA-Tyr  +~:  387 
4-ABA-His  None  39,202 
4-ABA-His  +  347 
16-4  None  None  8,310 
ABA-Tyr  None  60,560 
ABA-Tyr  +  257 
4-ABA-His  None  62,290 
4-ABA-His  +  150 
16-F1  None  None  17,817 
ABA-Tyr  None  150,130 
ABA-Tyr  +  97 
4-ABA-His  None  146,897 
4-ABA-ttis  +  57 
16-F2  None  None  6,550 
ABA-Tyr  None  138,290 
ABA-Tyr  +  257 
4-ABA-ttis  None  l 2,747 
4-ABA-His  +  97 
* See note to Table VI. 
~c 1 ~,g of protein A purified protein per culture. 
different response patterns to closely related compounds, providing extremely useful 
tools  for  investigation  of T  cell  specificity,  antigen  receptors,  and  cell  interaction 
phenomena, 
Discussion 
The results presented here demonstrate that  (a)  the murine T  lymphocyte response 
to  the  simple synthetic  antigen  ABA-Tyr is  under  genetic  control;  (b)  the  genetic 
control  is restricted to  the  I-A and/or  I-E loci of the H-2 complex;  (c)  high-respon- 
siveness is  dominant  in  the hybrid progeny of high  and  low  responder parents;  (d) 
cloned lines ofABA-responsive T  cells are either I-A or I-E restricted in their responses; 
and  (e) clones show marked differences in antigen specificity. 
All strains of mice used in this study mounted significant proliferative responses to 
ABA-Tyr,  but  H-2 b  haplotype  strains  were  markedly  weaker  than  those  of other 
haplotypes,  regardless of non-H-2  genetic  background.  The  "low"  and  "high"  re- 
sponses  averaged  3  and  20  times  above  background  in  the  proliferative  assay, 
respectively (Table  II).  This  genetic control  was  more  precisely mapped  using  B10 
recombinant  strains  as  well  as  monoclonal  anti-Ia  k  antibodies  to  block  antigen- 
induced proliferative responses. Thus, mice that were b haplotype at both the I-A and 
I-E loci  were  low  responders,  whereas  those  that  were  non-Ia  b at  either  locus were 
high  responders  (Table  IV).  Blocking experiments  with  monoclonal  anti-I-A  k and 
anti-I-E  k  reagents  (Table  IV)  supported  the  conclusion  that  ABA-Tyr  could  be HERTEL-WULFF ET  AL.  995 
presented  to T  cells in  the context  of either I-A or I-E. This conclusion  was given 
more weight  by analysis of the genetic restriction  of antigen-reactive cloned T  cell 
lines. Of 15 clones tested, only one (16-5)  was I-E  ~ restricted on the basis of blocking 
with anti-Ia monoclonal antibody (Table VI). Furthermore, this clone did not respond 
to ABA-Tyr presented by B 10.A(4R)  feeder cells (I-A  k, I-E  b)  (Table VII). However, 
the experiments using feeder cells of different H-2 haplotype as antigen presenters to 
clone  16-5 were inconclusive because a strain that was I-A~,A~,I-A~,E~ was unavaila- 
ble. The clone did not  respond to antigen  presented by B 10.A(3R)  cells, which  are 
I-A~,E~ and thereby differ from A/J in the I-E~ chain. 
The cumulative evidence clearly indicates that T  cells responsive to ABA-Tyr can 
"see" antigen in the context of either I-A or I-E, with a decisive statistical preference 
for  I-A.  This  represents  the  first  demonstration  that  a  particular  defined  epitope 
(ABA-Tyr) can be presented to responding T  cells in the context of more than one Ia 
product. 
Analysis of the fine antigen  specificity of the T  cell clones revealed that  they fell 
into  three categories with respect  to responsiveness to the structurally  related com- 
pound 4-ABA-His (Table VIII). One group of clones, exemplified by 16-4 and  16-F1, 
responded to the tyrosine and histidine derivatives equally. A second set, exemplified 
by  clones  16-2  and  16-F2,  made  responses  to  the  histidine  compound  that  were 
markedly weaker and readily distinguishable from those to the homologous tyrosine 
compound. The third group failed to mount responses significantly above background 
to  4-ABA-His.  Thus,  the  clones  manifest  clearly differing specificities  for nominal 
antigen,  and  a  detailed  structural  comparison  of their antigen  receptors will  be of 
great interest. It was also fascinating that none of the clones responded to 2-ABA-His, 
which at least appears to be chemically similar to the 4-isomer. It would be of obvious 
interest  to  determine  whether T  cells specific for 2-ABA-His can  be induced,  or if 
there  is  an  inherent  inability  to present  this  compound  to T  cells  in  an activating 
form. 
Summary 
The antigen-induced  proliferative response of lymph node cells (LNC)  from mice 
sensitized to the monofunctional antigen L-tyrosine-p-azobenzenearsonate (ABA-Tyr) 
was used to monitor genetic control. All strains tested mounted significant responses, 
but those that were H-2  b at both the I-A and I-E loci [B10., B6., B10.A(18R), A.BY, 
and  C3H.SW]  gave consistently  weaker  responses  than  other  haplotypes.  The  F1 
progeny of matings between high and low responder phenotype parents (DBA/2 and 
B6, respectively) were high responders, establishing the dominance of the responder 
trait.  Proliferative responses of LNC  to ABA-Tyr were blocked by the  appropriate 
anti-Ia monoclonal reagents. For example, B10.A(4R)  LNCI (I-A  k, I-E  b) were blocked 
by anti-I-A  k, whereas B10.A(3R)  LNC  (I-A  b, I-E  k) were blocked by anti-I-E  k. Long- 
term cultures  of T  cell lines specifically reactive to ABA-Tyr were established  from 
LNC of A/J mice immunized with ABA-Tyr and were cloned by limiting dilution. 
The proliferative responses to ABA-Tyr of 14 out of 15 clones tested were I-A restricted 
on the basis of activation by antigen-presenting cells from appropriate recombinant 
strains and the blocking activity of the monoclonal anti-Ia antibodies. The response 
of the other clone was I-E restricted.  The fine antigen  specificity of the clones was 
studied  using structural  analogs of the homologous antigen  to induce  proliferation. 996  ARSONATE-SPECIFIC MURINE  T  CELL CLONES 
The clones could be divided into three types with respect to responsiveness to ABA- 
histidine (ABA-His). One group responded about equally well to ABA-His and ABA- 
Tyr. A  second set  responded less strongly to ABA-His than to ABA-Tyr, while the 
third showed no response above background to ABA-His. In all instances, the ABA- 
His-responding clones discriminated exquisitely between the 2-azo and 4-azo histidine 
isomers, responding only to the 4-azo compound. These T  cell clones provide extremely 
useful tools  for  studies of T  cell specificity, antigen recognition and  lymphoid cell 
interaction systems. 
Received  for publication 20 September 1982 and in revised  form 25 October 1982. 
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